BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37458983)

  • 1. Development of lung cancer risk prediction models based on F-18 FDG PET images.
    Choi K; Park JS; Kwon YS; Park SH; Kim HJ; Noh H; Won KS; Song BI; Kim HW
    Ann Nucl Med; 2023 Oct; 37(10):572-582. PubMed ID: 37458983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparameter diagnostic model based on
    Li C; Luan X; Bi X; Chen S; Pan Y; Zhang J; Han Y; Xu X; Wang G; Xu B
    BMC Cancer; 2023 Feb; 23(1):119. PubMed ID: 36747196
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
    Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a
    Guo HY; Lin JT; Huang HH; Gao Y; Yan MR; Sun M; Xu WP; Yan HH; Zhong WZ; Yang XN
    Clin Lung Cancer; 2020 Jan; 21(1):47-55. PubMed ID: 31474376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of
    Yoon HY; Lee SH; Ha S; Ryu JS; Song JW
    J Korean Med Sci; 2021 Oct; 36(41):e257. PubMed ID: 34697928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Gu J; Ren Y; Chen X; Jiang Y; Zhou W; Wang L; Han Y; Wang Q; Wu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):49-55. PubMed ID: 32376559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [
    Zhang L; Xu C; Zhang X; Wang J; Jiang H; Chen J; Zhang H
    Eur Radiol; 2023 Mar; 33(3):1757-1768. PubMed ID: 36222865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prone position PET/CT is useful in reducing gravity-dependent opacity-related [
    Song YH; Moon JW; Kim YN; Woo JY; Son HJ; Lee SH
    Eur Radiol; 2023 Nov; 33(11):8270-8278. PubMed ID: 37322163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
    Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
    Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of multiple metabolic and heterogeneity parameters of
    Shi A; Wang J; Wang Y; Guo G; Fan C; Liu J
    Ann Nucl Med; 2022 Apr; 36(4):393-400. PubMed ID: 35084711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
    Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal [
    Jiang Y; Wu H; Zhao Y; Cui Y; Dai J; Huang S; Li C; Mao H; Ju S; Peng XG
    Eur Radiol; 2023 Apr; 33(4):2561-2573. PubMed ID: 36350393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma].
    Guo Y; Yao ZM; Chen M; Chen CX
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):555-561. PubMed ID: 35754230
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
    Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
    Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparameter diagnostic model based on
    Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J
    BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.